Axxam

Axxam is a Milan-based, privately-held contract research organization providing integrated early discovery services from target assessment to lead generation. Operating as a high-tech CRO, it serves a diverse client base including pharma, biotech, agrochemical companies, and academic groups, utilizing advanced technologies like AI/ML and its proprietary AXXSense platform. The company is revenue-generating, holds multiple ISO certifications, and has been recognized for sustainability, positioning itself as a specialized partner in the complex pre-clinical discovery landscape.

Integrated drug discovery platform featuring high-throughput screening (HTS), proprietary AXXSense platform for industrial bioactives, and application of AI/ML for target identification and compound library design.

Axxam competes in the fragmented drug discovery CRO market against large global players (e.g., Charles River, Eurofins) and specialized boutique firms. Its differentiation lies in deep expertise in complex assay development and HTS, an integrated service model from target-to-lead, and diversification into non-pharma sectors like flavors and agrochemicals.